Capecitabine: 133 Real Stories

133 stories match capecitabine. 107 of them mention surgery.

Cancer Stories

A patient, who was diagnosed with Stage IV Gastric AdenocarcinomaGastric Cancer

Sjögren syndrome during nivolumab treatment for HER2-positive metastatic gastric cancer

Patient Info: Anonymized, male, 60s | Stage IV

Biomarkers: HER2-positive

Metastatic Site: liver, lungs, adrenal gland

One year after nivolumab was stopped, the shrinkage of lung metastases was maintained and the adrenal metastasis remained unchanged, although severe dry-mouth symptoms from treatment-related Sjögren syndrome persisted.

PubMed Central
OutcomeStable Disease
A patient, who was diagnosed with Invasive Lobular CarcinomaBreast Cancer

A New Breast Cancer Arising Beneath an Accessory Nipple

Patient Info: Anonymized, Female, 40s

Biomarkers: ER 5%; PR 5–10%; HER2-negative.

After chemotherapy, surgery, endocrine therapy, proton radiation, and later reconstruction revision, she was currently without evidence of disease.

PubMed Central
OutcomeCancer-Free / NED
Allison, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Allison's Survivor Story

Patient Info: Allison, Female, Under 40 | Stage III

As of August 2020, Allison reported no evidence of disease on follow-up scans while continuing survivorship care after rectal-cancer treatment.

The Patient Story
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Lobular Breast Cancer Spread Into a Nasal Tumor

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: Metastatic lobular focus: ER 8/8; PR 8/8; HER2-negative; E-cadherin-negative.

Metastatic Site: liver; bone; right nasal cavity within an olfactory…

The nasal lesion was removed with no residual local disease on imaging, and capecitabine was restarted while oncology follow-up continued for metastatic breast cancer.

PubMed Central
OutcomeCare Ongoing
A patient, who was diagnosed with Colorectal AdenocarcinomaColorectal Cancer

Stage III rectal adenocarcinoma with concurrent intermediate-risk prostate cancer

Patient Info: Anonymized, Male, 60s

Biomarkers: Rectal cancer CEA was not elevated. Prostate cancer PSA was high before treatment and low after radiation.

The rectal tumor achieved pathologic complete response with no residual tumor and 0 of 13 lymph nodes involved. Surveillance CT at 10 months showed no local recurrence or distant metastasis, and PSA remained low 1 year after operation.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage III Invasive Ductal CarcinomaBreast Cancer

Dramatic chemotherapy response in stage IIIB triple-negative breast cancer

Patient Info: Anonymized, Female, 40s | Stage III

Biomarkers: ER-negative; PR-negative; HER2-negative; BRCA1-negative; BRCA2-negative; germline FLCN c.1285delC associated with Birt-Hogg-Dubé syndrome; tumor TP53 p.T150fs.

Eighteen months after surgery, she had no recurrence following a dramatic chemotherapy response, bilateral mastectomy, chest-wall radiation, and adjuvant capecitabine.

PubMed Central
OutcomeCancer-Free / NED
Vanessa, who was diagnosed with Stage III Invasive Ductal CarcinomaBreast Cancer

Stage III Invasive Ductal Carcinoma: Vanessa's Survivor Story

Patient Info: Vanessa Sanders, Female, Under 40 | Stage III

As of November 2019, Vanessa had shown no evidence of disease for 15 years after clinical-trial chemotherapy, breast-conserving surgery and 6 weeks of radiation for Stage III invasive ductal breast cancer.

MD Anderson
OutcomeCancer-Free / NED
A patient, who was diagnosed with Colorectal AdenocarcinomaColorectal Cancer

Pemphigus Vulgaris After Rectal Cancer Surgery and Ileostomy

Patient Info: Anonymized, Female, 50s | Stage Metastatic/Advanced

Clinicians found no evidence of residual internal malignancy during evaluation of her skin disease, and the pemphigus lesions healed after rituximab with remission maintained for 14 months.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Gastric CancerGastric Cancer

Stage IV gastric cancer presenting with chylothorax and lymphedema

Patient Info: Anonymized, female, 40s | Stage IV

Biomarkers: HER2-negative

Metastatic Site: distant lymph nodes, pleura, peritoneum

She died 6 months after the Stage IV gastric-cancer diagnosis despite chemotherapy and repeated treatment of the malignant pleural effusions.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Gastric CancerGastric Cancer

Gastric Cancer Metastasis to the Hand Treated With Radiation

Patient Info: Anonymized, Male, 50s | Stage Metastatic/Advanced

Metastatic Site: liver|adrenal glands|left hand bones

Radiation relieved the hand pain and swelling and restored movement. At 6 months, he remained alive and pain-free in the hand, while the underlying metastatic gastric cancer remained present.

PubMed Central
OutcomeLiving With Cancer
OM
Colorectal Cancer

Oxaliplatin-Related Muscle Breakdown During Colorectal Cancer Treatment

Patient Info: Anonymized, Male, 50s | Stage III

Biomarkers: CEA 1.01 ng/mL; CA 19-9 <0.6 U/mL

He recovered fully from rhabdomyolysis, completed adjuvant capecitabine, and entered follow-up without evidence of cancer recurrence.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

HER2-amplified metastatic colon cancer treated with afatinib after several therapies

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: RAS wild-type; BRAF wild-type; HER2 amplification; HER2 mutation

Metastatic Site: liver|abdominal wall|lung

After multiple treatment lines and a 3-month period of stable disease on afatinib, the cancer progressed again. He died in January 2018 from severe lung infection and kidney failure.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Colorectal AdenocarcinomaColorectal Cancer

Rectal Cancer Spreading to the Thyroid and Bones

Patient Info: Anonymized, Male, 40s | Stage Metastatic/Advanced

Biomarkers: CEA 2.75 ng/mL at diagnosis

Metastatic Site: thyroid|bones

His metastatic disease worsened after 3 cycles of bevacizumab and capecitabine. He declined further treatment and died at home within 2 months.

PubMed Central
OutcomeIn Memory